Generic Name and Formulations:
Mepenzolate bromide 25mg; tabs; contains tartrazine.
Indications for CANTIL:
Adjunct in peptic ulcer.
Use lowest effective dose. 1–2 tabs 4 times a day with meals and at bedtime.
Glaucoma. GU or GI obstruction (eg, pyloroduodenal stenosis, achalasia). Paralytic ileus. Intestinal atony of the elderly or debilitated. Unstable cardiovascular status in acute GI hemorrhage. Toxic megacolon. Complicated ulcerative colitis. Myasthenia gravis.
Autonomic neuropathy. Hepatic or renal disease. Ulcerative colitis. Hiatal hernia with reflux esophagitis. Coronary heart disease. CHF. Cardiac arrhythmias. Tachycardia. Hypertension. Prostatic hypertrophy. Hyperthyroidism. High environmental temperature. Aspirin sensitivity. Delayed gastric emptying time. Elderly. Pregnancy (Cat.B). Nursing mothers.
Additive anticholinergic effects with amantadine, class I antiarrhythmics (eg, quinidine), antihistamines, phenothiazines, benzodiazepines, MAOIs, narcotic analgesics (eg, meperidine), nitrates, nitrites, sympathomimetic agents, tricyclics, and other anticholinergics. Antagonizes antiglaucoma agents. May antagonize metoclopramide. May affect absorption of digoxin. Antacids may inhibit absorption; avoid.
Nausea, vomiting, constipation, dry mouth, mental confusion, drowsiness, dizziness, headache, blurred vision, urticaria, tachycardia, urinary retention or hesitancy, decreased sweating, insomnia.